CEFDINIR

SynDRA canonical compound SYN0002618 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	MPO
Mechanism of action	bacterial cell wall synthesis inhibitor
Indication	bronchitis \| otitis \| pharyngitis \| pneumonia \| sinusitis \| skin infections \| tonsillitis
Disease area	infectious disease \| otolaryngology \| pulmonary

All known targets

cefdinir monohydrate
cefdiel
cefnil
cefzon
Cefdinir anhydrous
Cefzon
BMY-28488
CI-983
FK-482
NSC-758926
Omnicef
CFDN
Cefdinirum
Cefdinyl
Cefdirnir
BMY 28488
PD-134393
Cefdinir [USAN:INN]
Cefdinirum [INN-Latin]
Cefzon (TN)
FR-80482
KS-1038
Omnicef (TN)
Cefdinir (JP15/USAN/INN)
Omnicef, FK-482, BMY-28488, PD 134393, CI-983, Cefdinir
(-)-(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-oxime
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
7-(2 (2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid
7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(hydroxyimino)acetamido]-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid
CI 983
FK 482
CHEBI:3485
CI0FAO63WC
NSC 758926
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(N-hydroxyimino)acetamido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Cefdinir 100 microg/mL in Acetonitrile
PD 134393